Seroba is a Dublin life sciences VC backing biotech and medtech companies across Europe. Its news feed shows portfolio company Alveus Therapeutics closing a $197M Series A in February 2026.
Auto-extracted from press releases.
Auto-detected from Seroba Life Sciences's website.
Product and business development background in pharma and biotech with neuroscience research experience.
Venture capital and investment banking background with focus on life sciences in continental Europe.
Corporate venture and technology transfer expertise with focus on product development and commercialization.
35+ years pharma industry experience in R&D, Commercial, BD and venture investments across Europe.
Pharmacology background, progressed from Investment Analyst to Partner in 2022.
Private equity and asset management background with VC experience at Truffle Capital.
Focus and check size from the firm's website. Website reachable as of Sept 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.